Skip to content

Precigen PGEN Issuance cost related to Warrants

Issuance cost related to Warrants at other companies

General Purpose Acquisition Corp.
 logo
General Purpose Acquisition Corp. GPAC
$648.86K
NextNav logo
NextNavNN
-$2.25M
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$3K-72.7%
NextNav logo
NextNavNN
-$2.25M
LCI Industries logo
LCI IndustriesLCII
$0-100%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.15M

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.93B+213%

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept pgen:IssuanceCostsRelatedToWarrants.

The official record: Precigen’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's issuance cost related to warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's issuance cost related to warrants?
Precigen (PGEN) reported issuance cost related to warrants of $0 in Q4 2025.
How has Precigen's issuance cost related to warrants changed year-over-year?
Precigen's issuance cost related to warrants decreased by 100.0% year-over-year, from $73K to $0.
What does issuance cost related to warrants mean?
Captures the direct costs incurred in the issuance of warrants, such as legal, accounting, and underwriting fees. Monitoring these costs provides insight into the efficiency of the company's capital raising activities and the total cost of equity financing.